Key result
Co-existing hypertension in type 2 diabetics was associated with a lower LF/HF ratio compared to normotensive diabetics, with no significant difference in other HRV parameters.
Why the study?
Does co-existing hypertension worsen cardiac dysautonomia measured by heart rate variability in type 2 diabetics?
Cross-Sectional (n=138)
Does co-existing hypertension worsen cardiac dysautonomia measured by heart rate variability in type 2 diabetics?
Answers are grounded in this paper and cite their sources.
In type 2 diabetics, treated hypertension with good blood pressure control does not significantly worsen cardiac dysautonomia beyond the effects of diabetes itself.
BACKGROUND: Co-existence of hypertension is known in three quarter of Indian type 2 diabetics, this duo having adverse additive effect on cardiovascular health including dysautonomia. Latter can be measured by simple 5min heart rate variability (HRV) using simple electrocardiogram, which if reduced indicates cardiac risk. OBJECTIVE: We compared HRV parameters between hypertensive and normotensive type 2 diabetics, looking for significant difference if any. MATERIALS AND METHODS: 98 hypertensive and 40 normotensive type 2 diabetics treated as outpatients were evaluated for disease control and risk stratification. Fivemin resting HRV was measured by Variowin HR, software based instrument, using standard protocols to record time domain, frequency domain and Poincare plot parameters. They were compared between groups for difference. RESULTS: Mean age was 56 and 51 years, duration 6 years and 4 years respectively in hypertensive (HT) and normotensive (NT) group of type 2 diabetics, which did not significantly differ in distribution of risk factors. There was poor glycaemic control (one third) in both groups and good pressure control in HT group. Both groups revealed all reduced HRV parameters with significant difference in-between only for LF/HF ratio (1.29 in HT vs 2.61 in NT group). CONCLUSION: Our findings of HRV suggest that in type 2 diabetics with poor glycaemic and good pressure control, hypertension as a co-existing factor does not make significant difference in cardiac dysautonomia emphasizing residual risk despite antihypertensive treatment and need for early HRV screening, strict glycaemic control and other interventions.
No takes yet. Share an insight, caveat, or question.
Solanki et al. (2016) conducted a cross-sectional in Type 2 diabetes (n=138). Hypertension vs. Normotensive was evaluated on LF/HF ratio. Co-existing hypertension in type 2 diabetics was associated with a lower LF/HF ratio compared to normotensive diabetics, with no significant difference in other HRV parameters.
Synapse has enriched 10 related papers. Consider them for comparative context: